These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8710917)

  • 1. Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis.
    Saito A; Yamazaki H; Rader K; Nakatani A; Ullrich R; Kerjaschki D; Orlando RA; Farquhar MG
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8601-5. PubMed ID: 8710917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis.
    Yamazaki H; Ullrich R; Exner M; Saito A; Orlando RA; Kerjaschki D; Farquhar MG
    J Am Soc Nephrol; 1998 Sep; 9(9):1638-44. PubMed ID: 9727372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
    Orlando RA; Kerjaschki D; Farquhar MG
    J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family.
    Saito A; Pietromonaco S; Loo AK; Farquhar MG
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9725-9. PubMed ID: 7937880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330.
    Pietromonaco S; Kerjaschki D; Binder S; Ullrich R; Farquhar MG
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1811-5. PubMed ID: 2408041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
    Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA
    J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
    Farquhar MG; Saito A; Kerjaschki D; Orlando RA
    J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions.
    Orlando RA; Exner M; Czekay RP; Yamazaki H; Saito A; Ullrich R; Kerjaschki D; Farquhar MG
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2368-73. PubMed ID: 9122201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
    Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
    J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein.
    Wu H; Zhang GY; Knight JF
    Clin Exp Immunol; 2000 Jul; 121(1):157-64. PubMed ID: 10886254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-associated protein and members of the low density lipoprotein receptor family share a common epitope. An extended model for the development of passive Heymann nephritis.
    Hiesberger T; Hodits R; Ullrich R; Exner M; Kerjaschki D; Schneider WJ; Nimpf J
    J Biol Chem; 1996 Nov; 271(46):28792-7. PubMed ID: 8910522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
    Oleinikov AV; Feliz BJ; Makker SP
    J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
    Kanalas JJ; Makker SP
    J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex.
    Orlando RA; Kerjaschki D; Kurihara H; Biemesderfer D; Farquhar MG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6698-702. PubMed ID: 1495959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a pathogenic epitope involved in initiation of Heymann nephritis.
    Kerjaschki D; Ullrich R; Diem K; Pietromonaco S; Orlando RA; Farquhar MG
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11179-83. PubMed ID: 1280820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor.
    Raychowdhury R; Niles JL; McCluskey RT; Smith JA
    Science; 1989 Jun; 244(4909):1163-5. PubMed ID: 2786251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different molecular forms of rat kidney gp330, the dominant autoantigen of active Heymann nephritis.
    Jokhadze GG; Oleinikov AV; Kanalas JJ; Makker SP
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):711-3. PubMed ID: 7848267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin.
    Oleinikov AV; Zhao J; Makker SP
    Biochem J; 2000 May; 347 Pt 3(Pt 3):613-21. PubMed ID: 10769163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel autoantibody to plasminogen and its characterization in Heymann nephritis.
    Makker SP
    Clin Immunol Immunopathol; 1994 Jul; 72(1):105-13. PubMed ID: 8020183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.